X4 Pharmaceuticals CLO Derek Meisner resigns effective Aug 22, 2022

X4 Pharmaceuticals, Inc

Chief Legal Officer and Corporate Secretary Derek Meisner resigns effective August 22, 2022.
Resignation is to pursue another opportunity; not due to any disagreement with the company or board.
No replacement for Meisner has been announced as of the filing date.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Derek Meisner

Chief Legal Officer and Corporate Secretary

XFOR · X4 Pharmaceuticals, Inc

Effective: 2022-08-22
Filed: July 29, 2022, 7:59 PM ET

Derek Meisner provided X4 Pharmaceuticals, Inc. (the “Company”) with notice of his intent to resign from his position as Chief Legal Officer and Corporate Secretary of the Company, effective August 22, 2022, in order to pursue another opportunity.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Derek Meisner resigned as Chief Legal Officer and Corporate Secretary at X4 Pharmaceuticals, Inc.

Action: resigned
Role: Chief Legal Officer and Corporate Secretary

Exact text from the filing

Derek Meisner provided X4 Pharmaceuticals, Inc. (the “Company”) with notice of his intent to resign from his position as Chief Legal Officer and Corporate Secretary of the Company, effective August 22, 2022, in order to pursue another opportunity.

View on SEC.gov

X4 Pharmaceuticals, Inc filing history →

Source: SEC EDGAR

accession 0001193125-22-206598

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.